A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04395677

Recruitment Status : Recruiting

First Posted : May 20, 2020

Last Update Posted : February 3, 2021

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

AnHeart Therapeutics Inc.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	December 30, 2022
Estimated Study Completion Date :	December 31, 2025

To Top